Structure Therapeutics News

Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program

Seeking AlphaJul 25 07:01 ET

What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?

Zacks Jul 24 09:05 ET

Leerink Partners Maintains Structure Therapeutics(GPCR.US) With Buy Rating

Moomoo NewsJul 24 02:33 ET · Ratings

Buy Rating Backed by Strategic Partnership Opportunities and Strong Patent Portfolio for Structure Therapeutics

TipRanksJul 24 01:57 ET · Ratings

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsJul 22 07:31 ET · Ratings

Rivals Emerge to Ozempic and Zepbound -- but With a Lag -- Heard on the Street -- WSJ

WSJJul 19 07:00 ET

Express News | Shares of Weight Loss Stocks Are Trading Lower, Possibly on Continued Weakness Following Recent Weight Loss Data From Roche, Which Could Cause Competition Concerns for Companies in the Space

BenzingaJul 18 11:20 ET

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

BenzingaJul 17 13:28 ET

Express News | Structure Therapeutics Shares Are Trading Lower Following Weight Loss Data From Competitor Roche

BenzingaJul 17 11:38 ET

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

BenzingaJul 17 10:47 ET

Roche Obesity-pill Trial Results Weigh on Shares of Eli Lilly, Novo Nordisk

MarketWatchJul 17 09:03 ET

ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

BenzingaJul 17 08:21 ET

Peering Into Structure Therapeutics's Recent Short Interest

BenzingaJul 15 11:15 ET

These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey

Seeking AlphaJul 12 10:50 ET

This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment

Seeking AlphaJul 12 04:12 ET

JMP Securities Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $91

Moomoo NewsJul 11 10:31 ET · Ratings

Analysts' Top Healthcare Picks: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Armata Pharmaceuticals (ARMP)

TipRanksJul 11 09:50 ET

Pfizer Signals Progress on Obesity Pill, Boosting Stock

MarketWatchJul 11 08:31 ET

Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers

Seeking AlphaJul 5 15:04 ET

A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.

A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.

Zhitong FinanceJul 4 02:42 ET